Back to search

Sweden· SE-20250113000013

Imipenem/Cilastatin Noridem 500 mg/500 mg Pulver till infusionsvätska, lösning

A medicinal product containing cilastatin + imipenem, registered in Sweden by Noridem Enterprises Ltd.

Checked against Swedish Medical Products Agency (Sweden) on

Informational only — not a medical device.

SOURCE REGISTER · SESwedish Medical Products Agency (Sweden)normalisedImipenem/Cilastatin Noridem 500 mg/50…ATC—REGISTER NO.SE-20250113000013PACKS LISTED1CHECKEDOctober 1, 2026

The record

At a glance

Swedish Medical Products Agency (Sweden)
Active substance
Cilastatin + Imipenem
Manufacturer
Noridem Enterprises Ltd
Country
Sweden (SE)
ATC code
—
Reimbursed
Not published by this register
Source register
Swedish Medical Products Agency (Sweden)
Last checked
October 1, 2026

Packs & prices · 1

  • se_varunummer
    20250113000013

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same medicine, other countries

Cilastatin + imipenem in 11 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All cilastatin + imipenem products

Authorised across Europe · EMA

The same active substance is authorised in 26 EEA countries. Names it is sold under:

  • Austria · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Eberth
  • Bulgaria · Имипенем/Циластатин Аптафарма, Мирон
  • Cyprus · Imicilast, Imipenem + Cilastatina Venus Pharma
  • Czechia · Enaros, Imipenem/Cilastatin Aptapharma
  • Germany · Imipenem Cilastatin Panpharma, Imipenem/Cilastatin Basics
  • Denmark · Andatin, Imipenem/Cilastatin Noridem
  • Estonia · Imipenem/Cilastatin Kabi
  • Spain · Enaros, Imipenem/Cilastatina Aurovitas
  • Finland · Andatin, Imipenem/Cilastatin Noridem
  • France · Imipenem Cilastatine Panpharma, Imipenem Cilastatine Sun
  • United Kingdom (Northern Ireland) · Imipenem/Cilastatin Accord Healthcare, Imipenem/Cilastatin Fresenius Kabi
  • Greece · Imicil, Imipenem+cilastatin /Kabi
  • Croatia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Hungary · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Ireland · Imipenem/Cilastatin, Imipenem/Cilastatin Hikma Farmacêutica Portugal
  • Italy · Imipenem E Cilastatina Aurobindo, Imipenem E Cilastatina Hikma Farmacêutica
  • Lithuania · Imipenem/Cilastatin Sun, Stinem
  • Latvia · Imipenem/Cilastatin Sun
  • Malta · Imipenem/Cilastatin Aptapharma, Miron
  • Netherlands · Imipenem/Cilastatine Fresenius Kabi, Imipenem/Cilastatine Hikma
  • Norway · Andatin, Imipenem/Cilastatin Fresenius Kabi
  • Poland · Imipenem + Cilastatin Aptapharma, Imipenem + Cilastatin Noridem
  • Portugal · Enaros, Imipenem + Cilastatina Aurovitas
  • Romania · Cilopen, Imipenem/Cilastatin Aptapharma
  • Slovenia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi
  • Slovakia · Imipenem/Cilastatin Aptapharma, Imipenem/Cilastatin Kabi

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/b490a8d5-2c52-498f-ba2f-9d02bfd20090
GET /v1/drugs/b490a8d5-2c52-498f-ba2f-9d02bfd20090?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "source": "lakemedelsverket",
  "doc_types": [
    "PL",
    "SmPC"
  ],
  "se_npl_id": "20250113000013",
  "product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20250113000013",
  "product_doc_link": "https://docetp.mpa.se/LMF/Imipenem_Cilastatin%20Noridem%20powder%20for%20solution%20for%20infusion%20SmPC_09001bee84c213f5.pdf"
}

See everything about cilastatin + imipenem.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.